Recent Updates
Recently added Catalysts
ARCT Positive Sentiment

Arcturus Therapeutics to Present at 2026 Jefferies Global Healthcare Conference

Tuesday, May 26, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Arcturus Therapeutics Holdings Inc. has announced its participation in the 2026 Jefferies Global Healthcare Conference. The company, known for its focus on messenger RNA medicines, aims to showcase its developments in therapeutics for liver and respiratory rare diseases. This presentation reflects Arcturus's commitment to engaging with the healthcare investment community.
Price reaction · baseline $7.21 (2026-05-26 close) · hit after-hours · clean, no other ARCT news in the window
day 0 close
+6.2%
day 1 · peak
+9.8%
day 3
+7.8%

Conference Participation Details

Jefferies Global Healthcare Conference
Date: November 18, 2025
Time: 11:30 a.m. GMT / 6:30 a.m. ET
Location: London
Format: Fireside Chat

How to Access

Investors and the general public can listen to both sessions live at:

https://investor.viatris.com

Archived versions will be available following the live events for a limited time.

Market Sentiment Analysis

POSITIVE FACTORS

  • Arcturus Therapeutics is actively engaging with investors.
  • The presentation highlights the company's focus on innovative mRNA medicines.
  • Participation in a notable healthcare conference indicates growth potential.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+73%
120-day peak, hindsight
Typical move
7.6%
average across 3 past catalysts
Cash runway
~28 mo
Minimal dilution risk
Lead asset
Metadoxine
Phase 2 · ADHD Predominantly Inattentive Type

Full Press Release Details

SAN DIEGO –(BUSINESS WIRE)–May 26, 2026– Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a messenger RNA medicines company focused on the development of liver and respiratory rare disease therapeutics, today announced that the Company will present at the following
The post Arcturus Therapeutics to Present at 2026 Jefferies Global Healthcare Conference appeared first on Arcturus Therapeutics .

Frequently Asked Questions

What will Arcturus present at the Jefferies Conference?

Arcturus will present its developments in messenger RNA medicines.

When is the Jefferies Global Healthcare Conference?

The conference is scheduled for 2026.

What focus areas does Arcturus specialize in?

Arcturus specializes in liver and respiratory rare disease therapeutics.

Where is Arcturus Therapeutics based?

Arcturus Therapeutics is based in San Diego.

ShareAdd on Google
Tags: ARCT Viatris Investor Conferences Healthcare Arcturus Therapeutics mRNA medicines Jefferies Conference healthcare therapeutics
Last updated: May 26, 2026

Conference Timeline

Nov 11, 2025
UBS Global Healthcare Conference
8:45 AM ET • Fireside Chat
Nov 18, 2025
Jefferies Global Healthcare
11:30 AM GMT • London

Biotech snapshot

Cash runway
$191M liquidity · $7M/mo burn
~28 mo
Minimal dilution risk
Lead asset
MetadoxinePhase 2
ADHD Predominantly Inattentive Type →

Catalyst track record

+73%
best trade around ARCT's most recent catalyst

Peak hindsight return over a 120-day window, across 3 tracked FDA/PDUFA catalysts for ARCT.

See every catalyst's timing & PoA →